Systematic review with meta-analysis: impact of baseline resistance-associated substitutions on the efficacy of glecaprevir/pibrentasvir among chronic hepatitis C patients.
Achintya Dinesh SinghSouvik MaitraNita SinghPayal TyagiAnzar AshrafRamesh Kumar. ShalimarPublished in: Alimentary pharmacology & therapeutics (2020)
Baseline NS3 or NS5a RAS, especially the NS5a substitutions-A30K, Y93H, decrease the odds of achieving SVR12 in genotype-3 CHC patients.